External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC

Conditions

• RET-fusion Non Small Cell Lung Cancer
• Lung Neoplasm
• Carcinoma, Non-Small-Cell Lung
• Respiratory Tract Neoplasms
• Thoracic Neoplasms
• Neoplasms by Site
• Neoplasms
• Lung Diseases
• Respiratory Tract Diseases
• Carcinoma, Bronchogenic
• Bronchial Diseases
• Head and Neck Neoplasms
• Carcinoma
• Neoplasms by Histologic Type
• Neoplasms, Germ Cell and Embryonal
• Neoplasms, Nerve Tissue
• Metastatic Non Small Cell Lung Cancer

Sponsor

Blueprint Medicines Corporation

Collaborators

• [object Object]